Fundamental analysis · SEC EDGAR · TTM through 31/03/2026
MOH · NYSE · Healthcare
Fundamental quality
34
out of 100
Source: SEC EDGAR · TTM through 31/03/2026
The score combines growth, profitability and financial strength. Here its financial strength weighs in its favor, while its growth drags it down the most.
| Year | Revenue | Net income | Free cash flow | Net debt |
|---|---|---|---|---|
| 2021 | 27,771 | 659 | 2,042 | -2,265 |
| 2022 | 31,974 | 792 | 682 | -1,830 |
| 2023 | 34,072 | 1,091 | 1,578 | -2,668 |
| 2024 | 40,650 | 1,179 | 544 | -1,739 |
| 2025 | 45,426 | 472 | -636 | -482 |
Between 2021 and 2025, revenue went from $27,771M to $45,426M (+64%) and net income went from $659M to $472M (-28%).
Annual figures in millions of U.S. dollars ($M) per SEC filings. Net debt is total debt minus cash.
Is Molina Healthcare, Inc. a profitable company?
Molina Healthcare, Inc. is profitable, with a net margin of 0.4%, though a thin one.
Does Molina Healthcare, Inc. have a lot of debt?
No. Molina Healthcare, Inc. has a net cash position: more cash than debt.
Is Molina Healthcare, Inc. growing?
Its revenue has grown 11.2% annualized in recent years.
Does Molina Healthcare, Inc. generate cash?
Yes. It converts about 0.6% of its revenue into free cash flow.
The thresholds are general and the system doesn't judge qualitative factors. See the full methodology and use this analysis as a first filter, never as a final decision.
Is Molina Healthcare, Inc. cheap or expensive?
That depends on the current price. Look it up, enter it in the tool and get the full valuation verdict (P/E against its sector).
Compute the valuation →Brokers you can use to invest in U.S. and European stocks.
The serious investor's standard →
Popular in the U.S. →
Other analyses
NVIDIA (NVDA) · Microsoft (MSFT) · Apple (AAPL) · Alphabet (Google) (GOOGL) · Amazon (AMZN) · Meta Platforms (META) · see more →